Dealmaking In Home Care Slows, Stabilizes In Home Health Due To Medicare Payment Rule 

After several months of home health dealmaking uncertainty sparked by the largest-ever proposed cut to Medicare home health payments, a softer-than-anticipated final rule has paved the way for greater investor confidence in the sector in 2026. 

Meanwhile, the non-medical home care industry, which reported several strong quarters of dealmaking, experienced the slowest quarter of dealmaking in 2025, according to a report from M&A advisory firm Mertz Taggart. 

“There are a number of highly acquisitive sponsor-backed portfolio companies in the space that are gearing up to exit in 2026, which means that they’ll be looking to scoop up a few more companies onto their platform to add additional cash flow before going to market,” Cory Mertz, managing partner at Mertz Taggart, said in a statement. “We’re also seeing elevated interest in private duty home care from strategic acquirers who are looking to diversify their payer mix.”

Advertisement

Private duty services are dramatically in demand in the pediatric space, experts have previously told Home Health Care News – though treating the population comes with specific challenges. 

In the non-medical home care sector overall, dealmaking volume continued a trend of slowing over each quarter of the year, and dipped to 11 completed deals. Notable deals include Amivie’s acquisition of Atrio Home Health Care, NexPhase Capital’s acquisition of Always Best Care and Addus Homecare’s $7.4 million acquisition of Texas-based Del Cielo Home Care Services.

“This transaction continues our acquisition and development strategy of enhancing our geographic coverage and density in Texas,” Addus CEO Dirk Allison previously said about the deal. “Going forward, our development team will continue to focus on both clinical and non-clinical acquisition opportunities to increase both the density and geographic coverage to our current states.”

Advertisement

While more certainty in the home health space is likely to lead to an uptick in dealmaking, Q4 2025 saw only three deals close in the sector, on par with Q4 2024.

“We’re seeing some buyers who were previously hesitant to take a risk with all the uncertainty start to get more comfortable looking at home health assets again,” Mertz said.

Notably, VitalCaring Group acquired the home health operations of Traditions Health, adding five states to the provider’s footprint. 

Hospice dealmaking, meanwhile, reached its highest volume since 2021, with 16 total transactions closed during the quarter. Concerns regarding Medicare clawbacks have led to caution regarding deals in the space, leading Mertz to recommend a pre-market audit for any hospice operators considering a transaction in the next two to three years. 

In the home-based care sector overall, lowered interest rates kept buyers interested in clinching deals.

“There were some new curveballs throughout 2025 with macroeconomic uncertainty, a new administration eager to shake things up, regulatory concerns regarding the CMS home health rule and increased scrutiny of hospice compliance, but M&A activity remained relatively strong as the Fed continued to cut rates and buyers saw an opportunity to deploy the dry powder they’ve been holding on to,” Mertz said.

Companies featured in this article: